Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is an increase over the number of companies cited in the previous month.
The citations in the county include:
- The written instructions in your master manufacturing record did not include instructions for corrective action plans to use when specifications are not met.
- Your batch production records did not include an actual or representative label, or a cross-reference to the physical location of the actual or representative label specified in the master manufacturing record.
- You did not establish laboratory control processes for use of criteria for establishing appropriate specifications.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
LaCore Nutraceuticals, Inc. | Food and Cosmetics | 03/11/2024 | Corrective action plans |
LaCore Nutraceuticals, Inc. | Food and Cosmetics | 03/11/2024 | Batch record - label |
LaCore Nutraceuticals, Inc. | Food and Cosmetics | 03/11/2024 | Criteria for establishing specifications |